Regulation of HHLA2 expression in renal cell carcinoma and myeloid cells

被引：0
|
作者：
Shigemura, Tomonari [1 ]
Perrot, Nahuel [2 ]
Huang, Zimo [2 ]
Sheshdeh, Aseman Bagheri [3 ]
El Ahmar, Nourhan [3 ]
McDermott, David [2 ]
Signoretti, Sabina
Freeman, Gordon [1 ]
Mahoney, Kathleen [4 ]
机构：
[1] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[4] Harvard Med Sch, Dana Farber Canc Inst, Beth Israel Deaconess Med Ctr, Boston, MA USA
来源：
CANCER RESEARCH | 2023年 / 83卷 / 16期
关键词：
D O I：
10.1158/1538-7445.KIDNEY23-A005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A005
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Overexpression of HHLA2, a member of the B7 family, is associated with worse survival in human colorectal carcinoma
    Zhu, Ziwen
    Dong, Weiguo
    ONCOTARGETS AND THERAPY, 2018, 11 : 1563 - 1570
  • [42] Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein
    Janakiram, Murali
    Chinai, Jordan M.
    Fineberg, Susan
    Fiser, Andras
    Montagna, Cristina
    Medavarapu, Ramadevi
    Castano, Ekaterina
    Jeon, Hyungjun
    Ohaegbulam, Kim C.
    Zhao, Ruihua
    Zhao, Aimin
    Almo, Steven C.
    Sparano, Joseph A.
    Zang, Xingxing
    CLINICAL CANCER RESEARCH, 2015, 21 (10) : 2359 - 2366
  • [43] HHLA2 is expressed in pancreatic and ampullary cancers and increased expression is associated with better post-surgical prognosis
    Patrick P. C. Boor
    Kostandinos Sideras
    Katharina Biermann
    M. Hosein Aziz
    Iris J. M. Levink
    Shanta Mancham
    Nicole S. Erler
    Xudong Tang
    Casper H. van Eijck
    Marco J. Bruno
    Dave Sprengers
    Xingxing Zang
    Jaap Kwekkeboom
    British Journal of Cancer, 2020, 122 : 1211 - 1218
  • [44] HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1
    Jing, Chu-Yu
    Fu, Yi-Peng
    Yi, Yong
    Zhang, Mei-Xia
    Zheng, Su-Su
    Huang, Jin-Long
    Gan, Wei
    Xu, Xin
    Lin, Jia-Jia
    Zhang, Juan
    Qiu, Shuang-Jian
    Zhang, Bo-Heng
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [45] Enhancing hepatocellular carcinoma management: prognostic value of integrated CCL17, CCR4, CD73, and HHLA2 expression analysis
    Gan, Wei
    Sun, Bao-Ye
    Yang, Zhang-Fu
    Ye, Cheng
    Wang, Zhu-Tao
    Zhou, Cheng
    Sun, Guo-Qiang
    Yi, Yong
    Qiu, Shuang-Jian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (06)
  • [46] Expression of angiopoietins in renal epithelial and clear cell carcinoma cells: regulation by hypoxia and participation in angiogenesis
    Yamakawa, M
    Liu, LX
    Belanger, AJ
    Date, T
    Kuriyama, T
    Goldberg, MA
    Cheng, SH
    Gregory, RJ
    Jiang, CW
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 287 (04) : F649 - F657
  • [47] Apoptosis of renal cell carcinoma cells by expression of FADD
    Kwak, C
    Jeong, IG
    Jeong, H
    Ku, JH
    Lee, C
    Lee, SE
    JOURNAL OF UROLOGY, 2003, 169 (04): : 150 - 150
  • [48] Metal complex hydrogel loaded with paclitaxel for photocatalytic and fluorescence-responsive drug control on ampullary carcinoma by modulation of HHLA2
    Qi, Zijuan
    Yuan, Ying
    JOURNAL OF SOLID STATE CHEMISTRY, 2024, 338
  • [49] Coexpression of HHLA2 and PD-L1 on Tumor Cells Independently Predicts the Survival of Spinal Chordoma Patients
    Xia, Chao
    Huang, Wei
    Chen, Yun-Liang
    Fu, Hai-Bin
    Tang, Ming
    Zhang, Tao-Lan
    Li, Jing
    Lv, Guo-Hua
    Yan, Yi-Guo
    Ouyang, Zhi-Hua
    Yao, Nvzhao
    Wang, Cheng
    Zou, Ming-Xiang
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [50] Expression Profile and Clinical Significance of Immune Checkpoint Proteins B7-H4 and HHLA2 in Prostatic Adenocarcinoma
    Liao, Xiaoyan
    Miyamoto, Hiroshi
    Zhang, Dongwei
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 623 - 624
12345